drug development

Pharma Failures Actually Advance Medicine
Pharma Failures Actually Advance Medicine
Forbes
FDA
R&D
drug development
Pfizer
Torcetrapib
Flag link:
GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round
GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round
Fierce Biotech
GSK
Sitryx
immunometabolism
drug development
drug discovery
Flag link:
Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery
Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery
BioSpace
Sanofi
Evotex
drug development
LAB031
Flag link:
Are drug R&D costs exaggerated for effect? Researchers peg the median price of pivotal success at an economical $19M
Are drug R&D costs exaggerated for effect? Researchers peg the median price of pivotal success at an economical $19M
Endpoints
R&D
drug development
FDA
Flag link:
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Roche
Go Therapeutics
drug development
bispecific antibodies
Flag link:
Loyola is working on a new and improved CAR-T product, looking to overcome high-frequency side effects
Loyola is working on a new and improved CAR-T product, looking to overcome high-frequency side effects
Endpoints
Loyola University
CAR-T
drug development
Flag link:
Ionis, Rockefeller team find peripheral blood target for Alzheimer's
Ionis, Rockefeller team find peripheral blood target for Alzheimer's
BioCentury
Ionis Pharmaceuticals
Rockefeller University
Alzheimer's disease
drug development
Flag link:
Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
Motley Fool
Corbus Pharmaceuticals
cannabindoids
drug development
Flag link:
GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
Endpoints
GSK
R&D
drug development
Flag link:
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Fierce Pharma
JNJ
innovation
R&D
lung cancer
drug development
Flag link:
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Fierce Pharma
drug development
vaccines
HIV
tuberculosis
malaria
Flag link:
Elevian set up to pursue disputed approach to aging diseases
Elevian set up to pursue disputed approach to aging diseases
Fierce Biotech
Elevian
age-related disease
GDF11
drug development
Flag link:
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
CP Wire
antibiotics
Boehringer Ingelheim
drug development
Flag link:
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs
BioSpace
DMD
Duchenne Muscular Dystrophy
CRISPR
drug development
Flag link:
FDA Launches Pilot Program in Support of Complex Trial Designs for Drugs and Biologics
FDA Launches Pilot Program in Support of Complex Trial Designs for Drugs and Biologics
RAPS.org
FDA
clinical trials
drug development
Flag link:
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Roche
Genentech
Affimed
cancer immunotherapy
drug development
Flag link:
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
BioSpace
cancer
oncology
drug development
devices
Flag link:
Bluebird taps Gritstone for oncology cell therapy targets
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Bluebird Bio
Gritstone Oncology
oncology
T-cell receptors
drug development
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Artificial intelligence in drug discovery and diagnosis
Artificial intelligence in drug discovery and diagnosis
Pharmaforum
artificial intelligence
machine learning
diagnostics
drug development
Flag link:

Pages